title: Approach to lupus nephritis based upon randomized trials.
authors.affiliation: Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
authors.forename: A D
authors.initials: AD
authors.lastname: Steinberg
authors.forename: J
authors.initials: J
authors.lastname: Muir
authors.forename: D E
authors.initials: DE
authors.lastname: Scott
authors.forename: M F
authors.initials: MF
authors.lastname: Gourley
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008181:Lupus Nephritis / Q000188:drug therapy*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage
chemical_list: D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone